John M. Jureller serves as Independent Director of the Company. Mr. Jureller also serves on the board of directors of White Plains Hospital in White Plains, New York and is the Chairman of the finance committee of White Plains Hospital. Mr. Jureller served on the audit committees of Studio Moderna Holdings B.V. from 2011 to 2012 and Torex Retail Holdings Ltd. from 2009 to 2012. Since March 2020, Mr. Jureller has served as Chief Financial Officer of Knotel, Inc., a flexible workspace provider. From 2017 to February 2020, Mr. Jureller served as a Managing Director at Accordion Partners, a financial advisory firm. Mr. Jureller was an independent financial and management consultant from 2016 to 2017, and prior to that served as the Executive Vice President and Chief Financial Officer of Frontier Communications Corp. from 2013 until 2016. Prior to joining Frontier Communications Corp., Mr. Jureller served in a variety of senior financial roles with various companies including General Atlantic LLC, WestPoint International, Inc., AlixPartners, LLP, PepsiCo, Inc. and General Electric Capital Corporation. Mr. Jureller began his career with the corporate banking and leveraged finance groups at Bankers Trust Company. Mr. Jureller received a B.S. in Finance and an M.B.A. from Cornell University.
As the Independent Director of American Renal Associates, the total compensation of John Jureller at American Renal Associates is $455,004. There are 4 executives at American Renal Associates getting paid more, with Don Williamson having the highest compensation of $1,772,140.
John Jureller is 60, he's been the Independent Director of American Renal Associates since 2015. There are 5 older and 6 younger executives at American Renal Associates. The oldest executive at American Renal Associates Holdings Inc. is Robert Fish, 69, who is the Independent Director.
John's mailing address filed with the SEC is C/O ARAH, INC., 500 CUMMINGS CENTER, SUITE 6550, BEVERLY, MA, 01915.
Over the last 8 years, insiders at American Renal Associates have traded over $0 worth of American Renal Associates stock and bought 2,870 units worth $63,140 . The most active insiders traders include Thomas W Erickson, Joseph A Carlucci y Syed T Kamal. On average, American Renal Associates executives and independent directors trade stock every 215 days with the average trade being worth of $4,293,860. The most recent stock trade was executed by Joseph A Carlucci on 9 June 2020, trading 416,720 units of ARA stock currently worth $533,402.
American Renal Associates executives and other stock owners filed with the SEC include: